On April 12, Tianlong was honored to participate in the scientific conference “Liquid Biopsy in the Era of Personalized Medicine”, hosted by Gia An 115 Hospital and the Gia An 115 Institute of Medical and Pharmaceutical Research and Training.
The event brought together over 200 experts, doctors, and researchers from Vietnam and abroad, fostering meaningful discussions on the latest advances in liquid biopsy technology and its role in cancer screening, early diagnosis, targeted therapy, and treatment monitoring.
At the event, Tianlong showcased our cutting-edge solutions for pharmacogenomics, personalized medicine and infectious disease diagnostics, highlighting our commitment to supporting healthcare innovation in Vietnam.
With a local office established in Vietnam, Tianlong is proud to be a part of the growing medical and biotech community here. We remain dedicated to working closely with our partners and professionals to enhance diagnostic capabilities and improve patient outcomes across the region.
